Home / Companies / Sumitomo Pharma Oncology, Inc.
Sumitomo Pharma Oncology, Inc. H-1B company data
Summary
Sumitomo Pharma Oncology, Inc. filed 6 H-1B labor condition applications (LCAs) with the U.S. Department of Labor between FY2022-FY2023.
Of those, 6 were certified (a 100% certification rate among adjudicated filings).
The filings span 5 distinct role titles across 3 worksites.
The most-sponsored role was Associate Director, Pharmacovigilance Systems (2 filings), with offered wages from $166,036 to $166,036.
Separately, USCIS H-1B Employer Data Hub records show 1 approved and 0 denied H-1B petitions for this employer.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Employer | LCA filings | Role titles | Worksites | Coverage | USCIS approvals | Top role | Sources | Open |
|---|---|---|---|---|---|---|---|---|
| Sumitomo Pharma Oncology, Inc. SUMITOMO PHARMA ONCOLOGY INC | 6 | 5 | 3 | FY2022 to FY2023 Latest decision 2023-05-02 | 1 | Associate Director, Pharmacovigilance Systems 2 filings | dol_oflc_lca, uscis_h1b_employer_data_hub | Profile |
Activity summary
| LCA filings | 6 |
| Certified LCAs | 6 |
| Denied LCAs | 0 |
| Role titles | 5 |
| Worksites | 3 |
| Latest decision | 2023-05-02 |
| USCIS approvals | 1 |
| USCIS denials | 0 |
Aliases and source names
| Aliases | Source Names | Sources |
|---|---|---|
| SUMITOMO PHARMA ONCOLOGY INC | Sumitomo Pharma Oncology, Inc., SUMITOMO PHARMA ONCOLOGY INC | dol_oflc_lca, uscis_h1b_employer_data_hub |
Top roles
| Title | SOC | LCA filings | Low wage min | High wage max |
|---|---|---|---|---|
| Associate Director, Pharmacovigilance Systems | 17-2031.00 Bioengineers and Biomedical Engineers | 2 | $166,036 | $166,036 |
| Clinical Data Manager | 19-1041.00 Epidemiologists | 1 | $106,745 | $106,745 |
| Manager, Quality Management Systems | 13-1041.07 Regulatory Affairs Specialists | 1 | $114,298 | $114,298 |
| Scientist I, Translational Biology | 19-1029.01 Bioinformatics Scientists | 1 | $109,408 | $109,408 |
| Senior Manager, Accounting | 13-2011.00 Accountants and Auditors | 1 | $148,526 | $148,526 |
Top markets
| City | State | Postal Code | LCA Count | Role Title Count | Wage Low Min | Wage High Max | First Fiscal Year | Latest Fiscal Year |
|---|---|---|---|---|---|---|---|---|
| Marlborough | MA | 01752 | 4 | 3 | 114,298 | 166,036 | 2,023 | 2,023 |
| Marlborough | MA | 1752 | 1 | 1 | 106,745 | 106,745 | 2,022 | 2,022 |
| Suite 100 | UT | 84043 | 1 | 1 | 109,408 | 109,408 | 2,023 | 2,023 |
Full company payload
| Company ID | company:sumitomo pharma oncology |
| Name | Sumitomo Pharma Oncology, Inc. |
| Normalized Name | sumitomo pharma oncology |
| Source Company Ids | company_dol_oflc_lca_sumitomo_pharma_oncology_inc, company_uscis_h1b_datahub_sumitomo_pharma_oncology_inc_tax_2369 |
| Source Names | Sumitomo Pharma Oncology, Inc., SUMITOMO PHARMA ONCOLOGY INC |
| Aliases | SUMITOMO PHARMA ONCOLOGY INC |
| Sources | dol_oflc_lca, uscis_h1b_employer_data_hub |
Names
{
"source_names": [
"Sumitomo Pharma Oncology, Inc.",
"SUMITOMO PHARMA ONCOLOGY INC"
],
"dba_names": [],
"name_variants": [
{
"value": "Sumitomo Pharma Oncology, Inc.",
"filing_count": 6,
"first_fiscal_year": 2022,
"latest_fiscal_year": 2023,
"source": "dol_oflc_lca"
},
{
"value": "SUMITOMO PHARMA ONCOLOGY INC",
"source": "uscis_h1b_employer_data_hub"
}
]
}Identifiers
[
{
"identifier_type": "tax_id_last_four",
"identifier_value": "2369",
"source": "uscis_h1b_employer_data_hub"
}
]LCA Activity
{
"lca_count": 6,
"case_count": 6,
"role_title_count": 5,
"worksite_count": 3,
"total_workers": 6,
"first_fiscal_year": 2022,
"first_received_date": "2022-05-17",
"latest_fiscal_year": 2023,
"latest_decision_date": "2023-05-02",
"certified_count": 6,
"denied_count": 0,
"status_breakdown": [
{
"value": "Certified",
"filing_count": 6,
"first_fiscal_year": 2022,
"latest_fiscal_year": 2023,
"source": "dol_oflc_lca"
}
],
"visa_class_breakdown": [
{
"value": "H-1B",
"filing_count": 5,
"first_fiscal_year": 2022,
"latest_fiscal_year": 2023,
"source": "dol_oflc_lca"
},
{
"value": "E-3 Australian",
"filing_count": 1,
"first_fiscal_year": 2023,
"latest_fiscal_year": 2023,
"source": "dol_oflc_lca"
}
],
"full_time_position_breakdown": [
{
"value": "Y",
"filing_count": 6,
"first_fiscal_year": 2022,
"latest_fiscal_year": 2023,
"source": "dol_oflc_lca"
}
]
}Petition Activity
{
"initial_approval": 0,
"initial_denial": 0,
"continuing_approval": 0,
"continuing_denial": 0,
"total_approval": 1,
"total_denial": 0,
"fiscal_years": [
"2023"
],
"year_metrics": [
{
"cities": [
"Marlborough"
],
"states": [
"MA"
],
"fiscal_year": 2023,
"naics_codes": [
"54"
],
"postal_codes": [
"01752"
],
"total_denial": 0,
"initial_denial": 0,
"total_approval": 1,
"initial_approval": 0,
"continuing_denial": 0,
"petition_count_id": "petition_count_uscis_h1b_archive_sumitomo_pharma_oncology_inc_tax_2369_2023",
"source_record_ids": [
"sr_uscis_h1b_datahub_2023_row_027509"
],
"continuing_approval": 1
}
]
}Addresses
{
"office_addresses": [
{
"address_kind": "office",
"raw_address": "MARLBOROUGH MA 01752",
"city": "Marlborough",
"state": "MA",
"postal_code": "01752",
"filing_count": 5,
"case_count": 5,
"first_fiscal_year": 2023,
"latest_fiscal_year": 2023,
"latest_decision_date": "2023-05-02",
"source_ids": [
"dol_oflc_lca"
]
},
{
"address_kind": "office",
"raw_address": "MARLBOROUGH MA 1752",
"city": "Marlborough",
"state": "MA",
"postal_code": "1752",
"filing_count": 1,
"case_count": 1,
"first_fiscal_year": 2022,
"latest_fiscal_year": 2022,
"latest_decision_date": "2022-05-24",
"source_ids": [
"dol_oflc_lca"
]
}
],
"worksite_addresses": [
{
"address_kind": "worksite",
"raw_address": "MARLBOROUGH MA 01752",
"city": "Marlborough",
"county": "Marlborough City",
"state": "MA",
"postal_code": "01752",
"filing_count": 4,
"case_count": 4,
"first_fiscal_year": 2023,
"latest_fiscal_year": 2023,
"latest_decision_date": "2023-04-10",
"source_ids": [
"dol_oflc_lca"
]
},
{
"address_kind": "worksite",
"raw_address": "SUITE 100 UT 84043",
"city": "Suite 100",
"county": "Utah",
"state": "UT",
"postal_code": "84043",
"filing_count": 1,
"case_count": 1,
"first_fiscal_year": 2023,
"latest_fiscal_year": 2023,
"latest_decision_date": "2023-05-02",
"source_ids": [
"dol_oflc_lca"
]
},
{
"address_kind": "worksite",
"raw_address": "MARLBOROUGH MA 1752",
"city": "Marlborough",
"county": "Marlborough City",
"state": "MA",
"postal_code": "1752",
"filing_count": 1,
"case_count": 1,
"first_fiscal_year": 2022,
"latest_fiscal_year": 2022,
"latest_decision_date": "2022-05-24",
"source_ids": [
"dol_oflc_lca"
]
}
],
"summary": {
"office_address_count": 2,
"worksite_address_count": 3,
"has_street_address_evidence": true,
"caveat": "LCA employer/worksite addresses are capped filing evidence scoped to matched source company names and should not be treated as verified headquarters without external validation."
}
}Geography
{
"states": [
"MA",
"UT"
],
"cities": [
"Marlborough",
"Suite 100"
],
"postal_codes": [
"01752",
"1752",
"84043"
],
"top_markets": [
{
"city": "Marlborough",
"state": "MA",
"postal_code": "01752",
"lca_count": 4,
"role_title_count": 3,
"wage_low_min": 114298,
"wage_high_max": 166036,
"first_fiscal_year": 2023,
"latest_fiscal_year": 2023
},
{
"city": "Marlborough",
"state": "MA",
"postal_code": "1752",
"lca_count": 1,
"role_title_count": 1,
"wage_low_min": 106745,
"wage_high_max": 106745,
"first_fiscal_year": 2022,
"latest_fiscal_year": 2022
},
{
"city": "Suite 100",
"state": "UT",
"postal_code": "84043",
"lca_count": 1,
"role_title_count": 1,
"wage_low_min": 109408,
"wage_high_max": 109408,
"first_fiscal_year": 2023,
"latest_fiscal_year": 2023
}
]
}Industry
{
"naics_codes": [
"541714",
"54"
],
"naics_breakdown": [
{
"value": "54171",
"filing_count": 5,
"first_fiscal_year": 2023,
"latest_fiscal_year": 2023,
"source": "dol_oflc_lca"
},
{
"value": "541714",
"filing_count": 1,
"first_fiscal_year": 2022,
"latest_fiscal_year": 2022,
"source": "dol_oflc_lca"
}
]
}Wage Summary
{
"annualized_low_min": 106745,
"annualized_high_max": 166036,
"annualized_low_avg": 135174.833333333
}Trend
[
{
"fiscal_year": 2022,
"quarter": "Q3",
"lca_count": 1,
"case_count": 1,
"role_title_count": 1,
"worksite_count": 1,
"wage_low_min": 106745,
"wage_high_max": 106745,
"wage_low_avg": 106745
},
{
"fiscal_year": 2023,
"quarter": "Q1",
"lca_count": 1,
"case_count": 1,
"role_title_count": 1,
"worksite_count": 1,
"wage_low_min": 166036,
"wage_high_max": 166036,
"wage_low_avg": 166036
},
{
"fiscal_year": 2023,
"quarter": "Q2",
"lca_count": 2,
"case_count": 2,
"role_title_count": 2,
"worksite_count": 1,
"wage_low_min": 148526,
"wage_high_max": 166036,
"wage_low_avg": 157281
},
{
"fiscal_year": 2023,
"quarter": "Q3",
"lca_count": 2,
"case_count": 2,
"role_title_count": 2,
"worksite_count": 2,
"wage_low_min": 109408,
"wage_high_max": 114298,
"wage_low_avg": 111853
}
]Links
{
"roles": "/v1/roles?company=Sumitomo%20Pharma%20Oncology%2C%20Inc.",
"wages": "/v1/wages?company=Sumitomo%20Pharma%20Oncology%2C%20Inc.",
"trends": "/v1/trends?company=Sumitomo%20Pharma%20Oncology%2C%20Inc."
}Frequently asked questions
- Does Sumitomo Pharma Oncology, Inc. sponsor H-1B visas?
- Yes. Sumitomo Pharma Oncology, Inc. filed 6 H-1B labor condition applications with the U.S. Department of Labor (FY2022-FY2023), of which 6 were certified. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
- How many H-1B applications has Sumitomo Pharma Oncology, Inc. filed?
- Sumitomo Pharma Oncology, Inc. has 6 H-1B LCA filings on record spanning FY2022-FY2023 across 5 role titles and 3 worksites.
- What roles does Sumitomo Pharma Oncology, Inc. sponsor for H-1B?
- The most common H-1B role at Sumitomo Pharma Oncology, Inc. is Associate Director, Pharmacovigilance Systems (2 filings). Other frequent roles include Clinical Data Manager, Manager, Quality Management Systems, Scientist I, Translational Biology, Senior Manager, Accounting.
- What wages does Sumitomo Pharma Oncology, Inc. offer H-1B workers?
- For its most-sponsored role (Associate Director, Pharmacovigilance Systems), Sumitomo Pharma Oncology, Inc. reported offered wages ranging from $166,036 to $166,036 in DOL LCA filings.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/companies?q=sumitomo+pharma+oncology+inc&limit=5JSON